CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 期刊简介

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS
英文简介:

Therapeutic uses of a variety of drug carrier systems have significant impact on the treatment and potential cure of many chronic diseases, including cancer, diabetes mellitus, psoriasis, parkinsons, Alzheimer, rheumatoid arthritis, HIV infection, infectious diseases, asthma, and drug addiction. Scientific efforts in these areas are multidisciplinary, involving the physical, biological, medical, pharmaceutical, biological materials, and engineering fields.
Articles concerning this field appear in a wide variety of journals. With the vast increase in the number of articles and the tendency to fragment science, it becomes increasingly difficult to keep abreast of the literature and to sort out and evaluate the importance and reliability of the data, especially when proprietary considerations are involved. Abstracts and noncritical articles often do not provide a sufficiently reliable basis for proper assessment of a given field without the additional perusal of the original literature. This journal bridges this gap by publishing authoritative, objective, comprehensive multidisciplinary critical review papers with emphasis on formulation and delivery systems. Both invited and contributed articles are subject to peer review.

中文简介:(来自Google、百度翻译)

多种药物载体系统的治疗用途对许多慢性疾病的治疗和潜在治愈具有重大影响,包括癌症,糖尿病,牛皮癣,帕金森氏症,阿尔茨海默氏症,类风湿性关节炎,HIV感染,传染病,哮喘和药物成瘾。这些领域的科学工作是多学科的,涉及物理,生物,医学,制药,生物材料和工程领域。
有关该领域的文章发表在各种期刊上。随着文章数量的大量增加和科学碎片的趋势,越来越难以跟上文献,并整理和评估数据的重要性和可靠性,尤其是在涉及专有考虑的情况下。摘要和非关键文章通常无法为适当评估给定领域提供足够可靠的基础,而无需额外阅读原始文献。该期刊通过发表权威,客观,全面的多学科批判性评论论文来弥合这一差距,重点是制定和交付系统。邀请和投稿的文章都要经过同行评审。

期刊ISSN
0743-4863
影响指数
4.84
最新CiteScore值
4.90 查看CiteScore评价数据
最新自引率
43.20%
官方指定润色网址
https://www.deeredit.com/?type=ss1
投稿语言要求

Improve the quality of the paper, eliminate grammar and spelling errors, increase readability, ensure accurate communication of viewpoints, enhance academic reputation, and increase the chances of the paper being accepted.

建议点击这个网址:https://www.deeredit.com/?type=ss2,资深审稿专家为您评估稿件质量,提供针对性改进建议,最终可助您极大提升目标期刊录用率

期刊官方网址

hot

https://www.peipusci.com/?type=9
杂志社征稿网址

hot

https://www.peipusci.com/?type=10
通讯地址
BEGELL HOUSE INC, 50 CROSS HIGHWAY, REDDING, USA, CT, 06896
偏重的研究方向(学科)
医学-药学
出版周期
Bimonthly
出版年份
1984
出版国家/地区
UNITED STATES
是否OA
No
SCI期刊coverage
Science Citation Index Expanded(科学引文索引扩展)
NCBI查询
PubMed Central (PMC)链接 全文检索(pubmed central)
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 期刊中科院JCR 评价数据
最新中科院JCR分区
大类(学科)
小类(学科)
综述期刊
医学
PHARMACOLOGY & PHARMACY(药学)4区
最新的影响因子
4.84
最新公布的期刊年发文量
年度总发文量 研究类文章占比
18 0.00%
总被引频次 69
影响因子趋势图
近年的影响因子趋势图(整体平稳趋势)

2022年预警名单预测最新

CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 期刊CiteScore评价数据
最新CiteScore值
4.90
年文章数 18
SJR
0.730
SNIP
0.908
CiteScore排名
序号 类别(学科) 排名 百分位
1 Pharmacology, Toxicology and Pharmaceutics Pharmaceutical Science #46/166
2 Pharmacology, Toxicology and Pharmaceutics Pharmacology #115/297
CiteScore趋势图
CiteScore趋势图
CRITICAL REVIEWS IN THERAPEUTIC DRUG CARRIER SYSTEMS 投稿经验(由下方点评分析获得,0人参与,1007人阅读)
投稿录用比例: 较易
审稿速度: >12周,或约稿
分享者 点评内容
没有更多了~
Copyright © 2014-2019 晟斯医学 All Rights Reserved. 备案号:苏ICP备11037034号-5 版权所有:南京孜文信息咨询有限公司